
Compassion-Focused Care May Ease Distress in Alopecia, Psoriasis
Key Takeaways
- Comparative survey data showed alopecia associated with higher external shame and depression and lower self-compassion, while psoriasis was associated with higher anxiety.
- External shame, reflecting fear of others’ judgments, differed by condition status and correlated more strongly with depression and anxiety than internal shame, consistent with involuntary, visible appearance change.
Self-compassion partly explains why shame over visible skin conditions leads to depression and anxiety, a new study finds.
Body shame tied to visible skin conditions such as
When researchers modeled why external shame, or fear that others are judging one's appearance, translates into psychological distress, self-compassion explained a substantial share of that pathway: the mediation model accounted for 50% of the variance in depressive symptoms and 22% in anxiety symptoms.
“The impact of both conditions goes far beyond the skin, affecting various aspects of mental health, including anxiety, depression, and even suicidal ideation,” the authors explained. “The prevalence of psychological disorders among individuals with alopecia and psoriasis is often higher than in the general population, underscoring the importance of holistic care approaches that address both physical symptoms and emotional needs.”
How Common Are Shame and Distress in These Patients?
Alopecia and psoriasis are both autoimmune conditions with a visible physical footprint—hair loss in one and red, scaly plaques in the other. The study compared 377 adults from the general population with 78 people living with alopecia and 67 with psoriasis, with all participants completing validated self-report measures of body image shame, depression, anxiety, and self-compassion through an online survey conducted between February and April 2024.
Individuals with alopecia reported significantly higher external body shame, more depressive symptoms, and lower self-compassion than the general population sample. Those with psoriasis reported significantly more anxiety symptoms than the general population. The alopecia and psoriasis groups did not differ significantly from each other on any measure. Despite this burden, most participants were not receiving mental health support: 89.6% of those with psoriasis and 76.9% of those with alopecia reported no psychological or psychiatric care tied to their condition.
External Shame Matters More Than Internal Shame
The researchers distinguished between 2 forms of shame: internal shame, rooted in a person's own self-judgment, and external shame, driven by the belief that others are judging them. Only external shame differed significantly across groups, while internal shame did not, and external shame also showed stronger correlations with depressive and anxiety symptoms than internal shame did among patients with alopecia or psoriasis.
The authors suggested this pattern may reflect the involuntary, visible nature of these conditions, which can heighten concern about how others perceive a change in appearance that the patient did not choose and cannot easily conceal.
The Role of Self-Compassion
Self-compassion is treating oneself with kindness rather than harsh self-criticism during moments of suffering. Across the groups, it was moderately to strongly negatively correlated with shame and depressive symptoms and moderately correlated with anxiety symptoms. In formal mediation analyses using the combined alopecia and psoriasis sample (n = 145), external shame retained a significant direct effect on both depression and anxiety, even after accounting for self-compassion, but a substantial portion of each relationship ran indirectly through self-compassion.
Higher external shame was linked to lower self-compassion, and lower self-compassion was, in turn, linked to greater depressive and anxiety symptoms—a partial mediation pattern that held for both outcomes.
What Does This Mean for Treatment Planning?
There is a growing body of research showing that psychological burden significantly affects quality of life in alopecia and that nearly 80% of patients with alopecia areata report experiencing stigma.2,3 Visible dermatologic disease carries mental health consequences.
Treatment for children with alopecia is an unmet need, especially since this is a time of life when their self-concept is being formed, Brittany G. Craiglow, MD, FAAD, associate professor, adjunct of dermatology at Yale School of Medicine, who also practices at Middlebury Dermatology in Connecticut, explained in an interview with The American Journal of Managed Care®.4 She described treating young children who don’t want to see themselves in the mirror and who struggle to find friends to play with.
“I had a patient recently [whose] mom said she asked…if she was ugly,” she said. “This is a 4-year-old. ‘Am I ugly, Mommy?’ Because a kid at school told her that she was ugly, and so these [are the] experiences that kids are having. How is that shaping their life?”
The authors point to compassion-focused therapy, an approach designed explicitly to build self-kindness and regulate shame responses, as a candidate intervention worth testing in this population, potentially alongside standard dermatologic care.
Despite Limits, Study Points to Need for Psychological Screening
The study has notable limitations: its cross-sectional design precludes causal conclusions, its samples were relatively small and skewed heavily female, and participants self-selected into an online survey, which may not reflect the broader population of patients with alopecia or psoriasis.
The authors also noted that perceived condition severity showed no significant correlation with any psychological outcome measured. They called for larger, longitudinal studies using more formal severity measures and said future work should isolate which specific components of self-compassion—self-kindness, common humanity, or mindfulness—contribute most to easing psychological distress in this population.
Still, the authors argued that integrating psychological screening into routine dermatologic care could help close a gap that this study's own numbers illustrate starkly: most patients carrying this burden are not receiving any support for it.
The findings point to "the potential utility of compassion-focused therapies to mitigate body image shame and associated psychopathology in individuals living with visible dermatological conditions such as alopecia and psoriasis,” the authors concluded.
References
- Carreiras D, Simões R, Alves M. Beyond skin deep: self-compassion mediates the link between body shame and psychopathology in people with alopecia and psoriasis. Health Psychology Report. 2026;14(3):223-233. doi:10.5114/hpr/215239
- McNulty R. Psychological burden of alopecia significantly impacts quality of life. AJMC. October 30, 2025. Accessed August 24, 2026.
https://www.ajmc.com/view/psychological-burden-of-alopecia-significantly-impacts-quality-of-life - AJMC Contributor. Patients with alopecia report high rates of internal, external stigma. AJMC. September 11, 2025. Accessed August 24, 2026.
https://www.ajmc.com/view/patients-with-alopecia-report-high-rates-of-internal-external-stigma - Jeremias S, Craiglow BG. Closing evidence gaps in managed care for pediatric alopecia areata: a Q&A with Brittany Craiglow, MD. AJMC. August 17, 2026. Accessed August 24, 2026.
https://www.ajmc.com/view/closing-evidence-gaps-in-managed-care-for-pediatric-alopecia-areata-a-q-a-with-brittany-craiglow-md




